Blue Edge Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Blue Edge Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$851K	Hold	5,377	–	–	0.1%	86
2026 Q1	$687K	Hold	5,377	–	–	0.09%	90
2025 Q4	$656K	Hold	5,377	–	–	0.09%	90
2025 Q3	$539K	Hold	5,377	–	–	0.08%	90
2025 Q2	$446K	Hold	5,377	–	–	0.07%	96
2025 Q1	$436K	Hold	5,377	–	–	0.07%	92
2024 Q4	$484K	Hold	5,377	–	–	0.08%	88
2024 Q3	$531K	Hold	5,377	–	–	0.08%	86
2024 Q2	$499K	Hold	5,377	–	–	0.08%	88
2024 Q1	$510K	Buy	+5,377	New	+$499K	0.09%	88

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Blue Edge Capital's XBI Position: Q2 2026 in Review

Blue Edge Capital held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 5,377 shares worth $851K. The position accounts for 0.1% of the portfolio, ranked #86.

Blue Edge Capital first reported a position in XBI in Q1 2024 and has held it in 10 quarters since. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Blue Edge Capital held 5,377 shares of State Street SPDR S&P Biotech ETF worth $851K as of Q2 2026.
Blue Edge Capital left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.1% of Blue Edge Capital's portfolio in Q2 2026, its #86 holding.
Blue Edge Capital first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 10 quarters since.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Blue Edge Capital's 13F filing for Q2 2026, filed 17 Aug 2026.